2016
DOI: 10.7717/peerj.2717
|View full text |Cite
|
Sign up to set email alerts
|

Effect of common and experimental anti-tuberculosis treatments onMycobacterium tuberculosisgrowing as biofilms

Abstract: Much is known regarding the antibiotic susceptibility of planktonic cultures of Mycobacterium tuberculosis, the bacterium responsible for the lung disease tuberculosis (TB). As planktonically-grown M. tuberculosis are unlikely to be entirely representative of the bacterium during infection, we set out to determine how effective a range of anti-mycobacterial treatments were against M. tuberculosis growing as a biofilm, a bacterial phenotype known to be more resistant to antibiotic treatment. Light levels from b… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
0
2

Year Published

2018
2018
2021
2021

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 27 publications
0
13
0
2
Order By: Relevance
“…M. abscessus BSG301 and M. marinum BSG101 [ 15 ] are stable bioluminescent derivatives transformed with the integrating plasmid pMV306G13ABCDE [ 16 ]. This allows light production to be used as a surrogate for bacterial viability [ 15 , 17 , 18 , 19 ]. Mycobacterial cultures were grown with shaking (200 rpm) in Middlebrook 7H9 broth (Fort Richard, Auckland, New Zealand) supplemented with 10% Middlebrook ADC enrichment media (Fort Richard, Auckland, New Zealand), 0.4% glycerol (Sigma-Aldrich, St. Louis, MO, USA), and 0.05% tyloxapol (Sigma-Aldrich, St. Louis, MO, USA).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…M. abscessus BSG301 and M. marinum BSG101 [ 15 ] are stable bioluminescent derivatives transformed with the integrating plasmid pMV306G13ABCDE [ 16 ]. This allows light production to be used as a surrogate for bacterial viability [ 15 , 17 , 18 , 19 ]. Mycobacterial cultures were grown with shaking (200 rpm) in Middlebrook 7H9 broth (Fort Richard, Auckland, New Zealand) supplemented with 10% Middlebrook ADC enrichment media (Fort Richard, Auckland, New Zealand), 0.4% glycerol (Sigma-Aldrich, St. Louis, MO, USA), and 0.05% tyloxapol (Sigma-Aldrich, St. Louis, MO, USA).…”
Section: Methodsmentioning
confidence: 99%
“…Between measurements, plates were covered, placed in a plastic box lined with damp paper towels, and incubated with shaking at 100 rpm at 37 °C for M. abscessus and 28 °C for M. marinum . Bacterial luminescence was measured at regular intervals using a Victor X-3 luminescence plate reader (PerkinElmer, Boston, MA, USA) with an integration time of 1 s. We have defined the MIC as causing a 1 log reduction in light production, as previously described [ 17 , 18 ]. More detailed protocols are available at protocols.io (accessed on 24 May 2021) [ 20 , 21 ].…”
Section: Methodsmentioning
confidence: 99%
“…Between measurements, plates were covered, placed in a plastic box lined with damp paper towels, and incubated with shaking at 100 rpm at 37 • C for M. abscessus and 28 • C for M. marinum. We measured bacterial luminescence at regular intervals using a Victor X-3 luminescence plate reader (PerkinElmer) with an integration time of 1 s. We have defined the MIC as causing a 1 log reduction in light production, as previously described (Dalton et al, 2016(Dalton et al, , 2017. We have published a more detailed description of our methods on the protocol repository website protocols.io (Wiles and Grey, 2021c,d).…”
Section: Extract Screeningmentioning
confidence: 99%
“…Одним из наиболее значимых свойств возбудителя внутри БФ является резкое снижение его чувствительности к воздействию антибиотиков. МБТ не являются исключением: возбудитель внутри БФ в 20-1000 раз более устойчив к противотуберкулезным препаратам (ПТП) [6]. Однако продукция БФ клиничес кими штаммами туберкулеза, остается весьма загадочным феноменом.…”
Section: Introductionunclassified
“…Анализ более трех сотен клинических штаммов из двух областных противотуберкулезных учреждений Иркутска и Улан-Уде [3] показал, что в подавляющем большинстве случаев клинические изоляты МБТ не имеют способности к продукции БФ. Анализ литературы свидетельствует, что ни в одном из исследований за последние десятилетия нет описания масштабной продукции БФ клиническим штаммами, и все описанные эксперименты проведены на лабораторных штаммах, зачастую подвергнутых генной модификации [6,7,11,16]. В то же время в русскоязычной литературе 80-х гг.…”
Section: Introductionunclassified